Health and Medicine

A new study published in BMC Infectious Diseases reveals that people with latent toxoplasmosis (a harmless form of the disease) are more likely to be involved in a road traffic accident. These findings may well be due to the presence of cysts formed in nerves and muscle tissue, which may reduce the ability of infected individuals to concentrate.

Toxoplasmosis is a parasitic disease, which affects between 30-60% of people across the world. However, very few people have symptoms because our im

Research study shows promising results for non-surgical treatment of life threatening condition

Rodney White, MD, Chief of Vascular Surgery and Associate Chair, Department of Surgery at Harbor-UCLA Medical Center and Principal Investigator at the Research & Education Institute at Harbor-UCLA Medical Center (REI) is shedding new light on endovascular treatment of thoracic aortic aneurysms (TAAs). A life threatening condition caused by a weakening of the vascular wall of the aorta in th

Researchers at the University of Chicago have found a way to combine cancer chemotherapy with gene therapy designed to disrupt the growth of blood vessels to a tumor. The combination, tested in mice, is far more effective than standard chemotherapy and has no additional side effects. This innovative approach is described in the August issue of the Journal of Clinical Investigation.

This new approach evolved out of a similar system, now entering phase-2 human trials, that combines gene ther

According to the World Health Organization, Tuberculosis ( Mycobacterium tuberculosis or TB) will kill two million people this year, with the projected number of new infections over the next twenty years reaching a billion. A rapidly moving, constantly mutating disease, TB’s effects are made worse by its ability to quickly react to new drug treatments, becoming resistant to antibiotics. Searching for a way to improve treatment, a group of researchers from the University of Tennessee developed

For years, physicians have noticed surprising similarities in the factors that seem to trigger attacks in such episodic neurological disorders as migraine and dyskinesia. Common triggers include psychological stress, caffeine or alcohol ingestion, fatigue, hormonal fluctuations and exercise.

A new study shows that a mouse model can be used to investigate how these substances and environmental factors trigger symptomatic attacks. The researchers also identified two drugs that can prevent at

A new and somewhat controversial study published in the August issue of the Journal of Nuclear Medicine suggests that 18F-FDG PET results obtained after the first cycle of treatment can better predict progression-free survival in patients with aggressive non-Hodgkin’s lymphoma (NHL) or Hodgkin’s disease (HD) than PET scans conducted at the end of treatment.

Physicians at the Weill Medical College of Cornell and the New York Presbyterian Hospital in New York reported on 23 patients